[{"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209839"], "brand_name": ["SOLIFENACINE SUCCINATE"], "generic_name": ["SOLIFENACINE SUCCINATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-259", "69097-261"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SOLIFENACIN SUCCINATE"], "rxcui": ["477367", "477372"], "spl_id": ["13de71d6-5be1-49ee-b2cf-e3d7c8fd7b45"], "spl_set_id": ["74d4f207-2a8c-47e6-81f4-1b52f5e35b99"], "package_ndc": ["69097-259-02", "69097-259-05", "69097-259-15", "69097-261-02", "69097-261-05", "69097-261-15"], "is_original_packager": [true], "unii": ["KKA5DLD701"]}, "product_type": "Drugs", "event_id": "88090", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0660-2021", "product_description": "Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa, India Manufactured for Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL, 33323, NDC 69097-261-02.", "product_quantity": "7228 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210610", "center_classification_date": "20210715", "termination_date": "20240110", "report_date": "20210721", "code_info": "Lot #: GG90819, Exp. Date 06/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62664", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distribution was nationwide and to Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-101-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "37,441/100-tablet bottles", "reason_for_recall": "Subpotent; 9-month stability interval", "recall_initiation_date": "20120725", "center_classification_date": "20121221", "termination_date": "20131114", "report_date": "20130102", "code_info": "Lot 1093992 and 1094095, exp. date 9/2012"}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0147-2025", "product_description": "Ipana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot No.: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-35119", "more_code_info": ""}, {"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017512"], "brand_name": ["DIANEAL LOW CALCIUM WITH DEXTROSE"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"], "manufacturer_name": ["Vantive US Healthcare LLC"], "product_ndc": ["0941-0409", "0941-0411", "0941-0413", "0941-0415", "0941-0457", "0941-0459", "0941-0426", "0941-0427", "0941-0429", "0941-0424", "0941-0430", "0941-0433", "0941-0484", "0941-0487", "0941-0490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["799999", "800003", "800057", "800061", "800062", "800064", "800066", "800074", "800111", "800115", "800472", "800474"], "spl_id": ["36ea94f6-f614-9531-e063-6294a90aae55"], "spl_set_id": ["aa268d3f-7389-4f25-801f-5d4825495f08"], "package_ndc": ["0941-0411-05", "0941-0411-06", "0941-0411-07", "0941-0411-04", "0941-0411-11", "0941-0413-05", "0941-0413-06", "0941-0413-07", "0941-0413-01", "0941-0413-04", "0941-0415-05", "0941-0415-06", "0941-0415-04", "0941-0415-07", "0941-0415-01", "0941-0409-06", "0941-0409-05", "0941-0409-07", "0941-0409-01", "0941-0457-08", "0941-0457-02", "0941-0457-05", "0941-0457-01", "0941-0459-08", "0941-0459-02", "0941-0459-05", "0941-0459-01", "0941-0426-52", "0941-0426-53", "0941-0426-55", "0941-0427-52", "0941-0427-53", "0941-0427-55", "0941-0429-52", "0941-0429-53", "0941-0429-55", "0941-0424-51", "0941-0424-52", "0941-0424-53", "0941-0424-55", "0941-0430-51", "0941-0430-52", "0941-0430-53", "0941-0430-55", "0941-0433-51", "0941-0433-52", "0941-0433-53", "0941-0433-55", "0941-0484-01", "0941-0487-01", "0941-0490-01"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "94846", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide, Canada", "recall_number": "D-0587-2024", "product_description": "Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, For Intraperitoneal Administration Only, 6000 mL per bag, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.  NDC:  0941-0457-01", "product_quantity": "6,874 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.", "recall_initiation_date": "20240617", "center_classification_date": "20240706", "report_date": "20240717", "code_info": "Lot R24B25FA; Exp. 2/28/2026"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0272-2018", "product_description": "Medline DC Line Kit, Sterile, Single use only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "363 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDC1971; Lots: 175B1999;   Pack Number: DYNDC1971H; Lots: 17OB8570; 175B1999", "more_code_info": ""}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1089-2018", "product_description": "Acetylcysteine 10% Oph Solution, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots with expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85797", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.", "recall_number": "D-1332-2020", "product_description": "Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, a) 100 (NDC 62037-577-01) and b) 1000 (NDC 62037-577-10), Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa, Distributed by: Actavis Pharma, Inc., Parsippany, NJ", "product_quantity": "a) 15,329 bottles and b) 137 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200602", "center_classification_date": "20200619", "termination_date": "20240412", "report_date": "20200701", "code_info": "a) 1333338M, exp. date 08/2020, 1333339A, exp. date 08/2020;  b) 1354471A, exp. date 02/2021"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0360-2020", "product_description": "Lubricant Eye Drops Moisturizing Twin Pack Walgreens item #: 801477, Package Size: 2 x 15 mL, NDC 0363-0185-49", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 19095, Exp 04/21"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0587-2020", "product_description": "Fentanyl Citrate and Bupivacaine HCl and Morphine Sulfate in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-731-2015", "product_description": "Imiquimod active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "998 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL Chew Tablet may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD30140_40, EXP: 5/7/2014;  LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU, NDC 43292050022, Pedigree: AD30028_10, EXP: 5/7/2014.", "address_2": "", "product_quantity": "180 Chew Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL, Chew Tablet has the following codes    Pedigree: AD30180_10, EXP: 5/9/2014;  Pedigree: AD32325_1, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL Chew Tablet, Over The Counter, Distributed by: AidaPak Service, LLC,  NDC 58914001460", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-638-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-431-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles (NDC 60793-860-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "33,227 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64301, Exp. 4/13 and 65628, Exp. 7/13; b) 64300, Exp. 4/13 and 65765, Exp. 7/13"}, {"status": "Terminated", "city": "Deltona", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67471", "recalling_firm": "MyNicNaxs, Inc.", "address_1": "1012 Alpine Dr", "address_2": "N/A", "postal_code": "32725-7204", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1374-2014", "product_description": "Super Fat Burning Bomb Capsules, 400 mg, supplied in 30 count boxes, distributed by MyNicKnaxs, LLC, Deltona, FL", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Phenolphthalein and N-desmethylsibutramine", "recall_initiation_date": "20140124", "center_classification_date": "20140612", "termination_date": "20191002", "report_date": "20140618", "code_info": "ALL LOTS"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-749-2015", "product_description": "Lanthanum Carbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "550 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020825"], "brand_name": ["GEODON"], "generic_name": ["ZIPRASIDONE HYDROCHLORIDE"], "manufacturer_name": ["ROERIG"], "product_ndc": ["0049-0056", "0049-3960", "0049-3980", "0049-3990", "0049-3920", "0049-0052", "0049-0054", "0049-0058", "0049-0352", "0049-0354", "0049-0356", "0049-0358"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZIPRASIDONE HYDROCHLORIDE"], "rxcui": ["284548", "284549", "284550", "285127", "313776", "313777", "313778", "314286", "351223", "352228"], "spl_id": ["d3a9a678-f1c3-4883-92eb-5dbe77aa6464"], "spl_set_id": ["8326928a-2cb6-4f7f-9712-03a425a14c37"], "package_ndc": ["0049-3960-60", "0049-3980-60", "0049-3990-60", "0049-3920-20", "0049-3920-83", "0049-3920-01", "0049-3920-10", "0049-0052-60", "0049-0054-60", "0049-0056-60", "0049-0058-60", "0049-0352-60", "0049-0354-60", "0049-0356-60", "0049-0358-60"], "is_original_packager": [true], "upc": ["0300490056601", "0300490058605", "3304023990605", "0300490354608", "3304023960608", "0300490352604", "0300490054607", "0300490052603", "0300490356602", "0300490358606", "3304023980606"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["216X081ORU", "3X6SAX83JZ", "6UKA5VEJ6X"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1112-2022", "product_description": "Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83", "product_quantity": "1 carton/10 vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74847", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1459-2016", "product_description": "Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg,  90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90", "product_quantity": "40,631 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out-of-specification results in retained sample.", "recall_initiation_date": "20160803", "center_classification_date": "20160816", "termination_date": "20170202", "report_date": "20160824", "code_info": "Lot #: GS011692, GS011938, Exp 10/2017; GS012638, GS012639, Exp 11/2017"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "33 mL total", "code_info": "All lots distributed between November 2014 and May 2015;  03242015@36, 6/22/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "L-Arginine 100 mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1441-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82941", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1335-2019", "product_description": "Sermorelin/GHRP-2 &6 (9-9-9 mg) vials, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846", "product_quantity": "25 vials", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20190523", "center_classification_date": "20190607", "termination_date": "20210205", "report_date": "20190619", "code_info": "Lot #: 02182019:79 Exp. 08/17/2019; 04162019:86 Exp. 10/13/2019"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "548 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;    04102015@36, 7/9/2015; 03252015@36, 6/23/2015; 04012015@77, 6/30/2015; 04162015@49, 7/15/2015; 04292015@83; 7/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Polidocanol 1% Injection, Multi-Dose Vial, Sterile, Refrigerate,  The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1624-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-210-2014", "product_description": "Methylprednisolone 100mg/ml, 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "697 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "lot# 011213dan"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1123-2016", "product_description": "All doxycycline Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"country": "United States", "city": "Lake Forest", "address_1": "275 N Field Dr", "reason_for_recall": "Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL", "address_2": "", "product_quantity": "212,370 cartidges", "code_info": "Lot #10830LL, Exp. 1APR2013", "center_classification_date": "20120715", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "Morphine Sulfate Injection, USP,  4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge Unit with Luer Lock, packaged 10 Carpujects/carton, CII, Rx only, Hospira, Inc., Lake Forest, IL  ---- NDC 0409-1258-30", "report_date": "20120725", "classification": "Class I", "openfda": {}, "recalling_firm": "Hospira Inc.", "recall_number": "D-1419-2012", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "61624", "termination_date": "20150529", "more_code_info": "", "recall_initiation_date": "20120417", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-632-2015", "product_description": "Diphemanil Methylsulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "200 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0851-2019", "product_description": "Dr. King's SafeCare Rx Gambling, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955301028, NDC 57955-3011-2", "product_quantity": "3 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 063016G Exp. 06/19"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA215401"], "brand_name": ["XELSTRYM"], "generic_name": ["DEXTROAMPHETAMINE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-0205", "68968-0210", "68968-0215", "68968-0220"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["DEXTROAMPHETAMINE"], "spl_id": ["368e7b16-6dbd-4fe7-b2b1-732123f5fdf3"], "spl_set_id": ["0862f02a-72a8-41cc-8845-57cf4974bb6f"], "package_ndc": ["68968-0205-1", "68968-0205-3", "68968-0210-1", "68968-0210-3", "68968-0215-1", "68968-0215-3", "68968-0220-1", "68968-0220-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["TZ47U051FI"]}, "product_type": "Drugs", "event_id": "95701", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0055-2025", "product_description": "Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3", "product_quantity": "685 boxes", "reason_for_recall": "Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).", "recall_initiation_date": "20241031", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot # 95598, Exp 02/28/25"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91580", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0265-2023", "product_description": "Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  NDC: 17478-215-02", "product_quantity": "45,117 Bottles", "reason_for_recall": "Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.", "recall_initiation_date": "20230130", "center_classification_date": "20230208", "report_date": "20230215", "code_info": "Lot: 081031A, Exp 2/28/2023", "more_code_info": ""}, {"status": "Terminated", "city": "San Jose", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75230", "recalling_firm": "Leiter's Compounding", "address_1": "17 Great Oaks Blvd", "address_2": "N/A", "postal_code": "95119-1359", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0012-2017", "product_description": "Cefuroxime Sodium 10 mg/mL in 0.9% Sodium Chloride  (Injection) 1 mL Total Volume in a 2 mL Vial (Preservative Free), Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-007-35", "product_quantity": "76,315 total units, all products", "reason_for_recall": "Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters", "recall_initiation_date": "20160920", "center_classification_date": "20161012", "termination_date": "20170503", "report_date": "20161019", "code_info": "All unexpired lots;  Expirations dates of 09/24/2016 to 02/06/2017"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-626-2015", "product_description": "Dexmedetomidine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "130 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0420-2022", "product_description": "Phenylephrine HCl/Tropicamide, Sterile Ophthalmic Solution, 2.5%/1%, 15 mL per dropper, Multiple Dose Droptainer for Topical Ophthalmic Use, Edge Pharma, LLC, 856 Colchester, VT 05446, NDC 05446-0815-01", "product_quantity": "363 droptainers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "09-2021-15@1 12/28/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89986", "recalling_firm": "McKesson Corporation dba McKesson Drug Company", "address_1": "4853 Crumpler Rd", "address_2": "N/A", "postal_code": "38141-8301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States including Guam and the Northern Mariana Islands.", "recall_number": "D-0847-2022", "product_description": "Halobetasol Propionate Ointment 0.05% Net Wt., 50 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-998-67", "product_quantity": "13, 200 tubes", "reason_for_recall": "CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.", "recall_initiation_date": "20220421", "center_classification_date": "20220505", "report_date": "20220511", "code_info": "Lots: 15720, Exp.: 06/30/2022; 16449 Exp.: 02/28/2023; 16450, Exp.: 02/26/2023"}, {"country": "United States", "city": "Richland", "address_1": "199 Interstate Dr Ste N", "reason_for_recall": "CGMP Deviations; deficiencies at the manufacturer  may result in assay or content uniformity failures", "address_2": "", "product_quantity": "2861 bottles", "code_info": "LOT # 29001501, EXP 07/17", "center_classification_date": "20161129", "distribution_pattern": "Nationwide", "state": "MS", "product_description": "Hyolev MB URINARY ANTISEPTIC Tablets, Each tablet for oral administration contains: Hyoscyamine Sulfate 0.12 mg, Methenamine 81 mg, Methylene Blue 10.8 mg, Phenyl Salicylate 32.4 mg, Sodium Phosphate Monobasic 40.8 mg, 90 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-301-90", "report_date": "20161207", "classification": "Class II", "openfda": {}, "recalling_firm": "Burel Pharmaceuticals Inc", "recall_number": "D-0155-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75566", "termination_date": "20170814", "more_code_info": "", "recall_initiation_date": "20161024", "postal_code": "39218-9433", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077954"], "brand_name": ["AZELASTINE HYDROCHLORIDE"], "generic_name": ["AZELASTINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0833"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["AZELASTINE HYDROCHLORIDE"], "rxcui": ["1797867"], "spl_id": ["6ace9d74-df2e-8b53-9bc8-72a794f3a21a"], "spl_set_id": ["4f58c203-f649-a18e-aaf3-70b0797652f4"], "package_ndc": ["60505-0833-5"], "is_original_packager": [true], "unii": ["0L591QR10I"]}, "product_type": "Drugs", "event_id": "62930", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1667-2012", "product_description": "Azelastine HCl Nasal Solution, 0.1 %, 137 mcg/spray, 30 mL bottle (200 Metered Sprays), Rx only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, NDC 60505-0833-5.", "product_quantity": "963,407 bottles", "reason_for_recall": "CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.", "recall_initiation_date": "20110615", "center_classification_date": "20120829", "termination_date": "20120918", "report_date": "20120905", "code_info": "Lot #: JK9130, JM0925, Exp 05/12; JN6514, Exp 07/12; JN1125, JN1127, Exp 08/12; JR5780, JR5782, Exp 12/12."}, {"status": "Ongoing", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761070"], "brand_name": ["FASENRA"], "generic_name": ["BENRALIZUMAB"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-1730", "0310-1830", "0310-1745"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["BENRALIZUMAB"], "rxcui": ["1989104", "1989109", "2205632", "2205634", "2679499", "2679502"], "spl_id": ["901977cc-c730-4b8b-9faf-ca24afc3589a"], "spl_set_id": ["da6aca1a-19ed-44a4-abb7-696c7d58b784"], "package_ndc": ["0310-1730-30", "0310-1730-85", "0310-1830-30", "0310-1830-85", "0310-1745-01", "0310-1745-95"], "is_original_packager": [true], "nui": ["N0000193803", "N0000193802"], "pharm_class_epc": ["Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]"], "unii": ["71492GE1FX"]}, "product_type": "Drugs", "event_id": "97760", "recalling_firm": "ASTRAZENECA PHARMACEUTICALS", "address_1": "950 Wind River Ln", "address_2": "", "postal_code": "20878-1974", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0028-2026", "product_description": "Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30", "product_quantity": "916 pre-filled syringes", "reason_for_recall": "Lack of Assurance of Sterility:", "recall_initiation_date": "20251008", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot YJ0152, Expiry: 01/31/2028.", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; TORSEMIDE, Tablet, 10 mg may be potentially mislabeled as    PYRIDOXINE HCL, Tablet, 50 mg, NDC 00536440801, Pedigree: AD30197_22, EXP: 5/9/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "TORSEMIDE, Tablet, 10 mg has the following code    Pedigree: AD30197_25, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TORSEMIDE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111091601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-595-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0374-2016", "product_description": "DMAE Dimethylaminoethanol Injection, 100mg/mL, 30mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "16 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"country": "United States", "city": "Dyersburg", "address_1": "450 US Hwy 51 Byp N", "reason_for_recall": "Superpotent and Subpotent drugs", "address_2": "", "product_quantity": "301 pellets", "code_info": "Lot Number 08082016@1, BUD:  02/04/2017", "center_classification_date": "20161108", "distribution_pattern": "U.S.", "state": "TN", "product_description": "Estradiol 3 mg Pellet, Compounded by: Wells Pharmacy Network", "report_date": "20161116", "classification": "Class III", "openfda": {}, "recalling_firm": "Wells Pharmacy Network, LLC", "recall_number": "D-0130-2017", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "75247", "termination_date": "20170329", "more_code_info": "", "recall_initiation_date": "20160919", "postal_code": "38024-3655", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66403", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-66403-007", "product_description": "Amlodipine Besylate and Benazepril HCl Capsules, 5 mg/20 mg, packaged in a) 100-count bottles (NDC 0378-6897-01) and b) 500-count bottles (NDC 0378-6897-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "60,506 bottles", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "recall_initiation_date": "20130913", "center_classification_date": "20131104", "termination_date": "20150723", "report_date": "20131113", "code_info": "Lot #: a) 2003169, 2003170, 2003171, 2003172, 2003173, 3043493; b) 2003168, 2003169, 3043493"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019430"], "brand_name": ["EPINEPHRINE"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["49502-101", "49502-102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "1870207"], "spl_id": ["b526b53a-fe41-462e-b453-745f36d136eb"], "spl_set_id": ["778ac6ae-6bcb-47a4-bcb3-8dd0da9f8836"], "package_ndc": ["49502-102-01", "49502-102-02", "49502-101-01", "49502-101-02"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1014-2022", "product_description": "Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma  NDC 49502-101-02", "product_quantity": "30 packs", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-328-2016", "product_description": "Testosterone Cypionate 200 mcg/mL in Sesame Oil Injection, packaged a) 5 mL and b) 100 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "261 vials", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 060815, Exp 09/08/2015; 061615, Exp 09/16/2015; 070615, Exp 10/06/2015; 071615, Exp 10/16/2015; and 080615, Exp 11/06/2015"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64729", "recalling_firm": "L. Perrigo Co.", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-318-2013", "product_description": "Liothyronine Sodium Tablets, USP,  5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc.,  Minneapolis, MN 55427,  NDC 0574-0220-01,", "product_quantity": "21,667 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: 3 month stability testing.", "recall_initiation_date": "20130312", "center_classification_date": "20130509", "termination_date": "20130724", "report_date": "20130515", "code_info": "12K714 exp. 12/13, 12K715 exp. 12/13"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0856-2023", "product_description": "XOPENEX (levalbuterol HCl) Inhalation Solution Concentrate, 1.25mg/3mL, 0.5 mL unit-dose vials, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL 60045. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-623-2015", "product_description": "Dexamethasone Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5010 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200909"], "brand_name": ["EZETIMIBE AND SIMVASTATIN"], "generic_name": ["EZETIMIBE AND SIMVASTATIN"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "product_ndc": ["43598-742", "43598-744", "43598-743", "43598-745"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EZETIMIBE", "SIMVASTATIN"], "rxcui": ["476345", "476349", "476350", "476351"], "spl_id": ["697ae8a7-2359-455f-9c21-e266f1c31288"], "spl_set_id": ["023ca87a-1b04-8c17-dc4f-e2758b0771e2"], "package_ndc": ["43598-742-30", "43598-742-90", "43598-742-10", "43598-744-30", "43598-744-90", "43598-744-10", "43598-743-30", "43598-743-90", "43598-743-05", "43598-745-30", "43598-745-90", "43598-745-05"], "is_original_packager": [true], "upc": ["0343598745909", "0343598742908", "0343598743905", "0343598744902"], "nui": ["N0000175589", "N0000000121", "N0000008553", "N0000175911"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["AGG2FN16EV", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "88798", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0084-2022", "product_description": "Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, a) 30 count (NDC 43598-743-30), b) 90 count (NDC 43598-743-90) bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA", "product_quantity": "a) 11,590 bottles b) 3,585 bottles", "reason_for_recall": "Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity", "recall_initiation_date": "20211005", "center_classification_date": "20211029", "termination_date": "20230216", "report_date": "20211110", "code_info": "a) L100158, exp 12/2022 b) L100159, exp 12/2022"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90270", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "N/A", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0975-2022", "product_description": "Only At Family Dollar AMBI Skincare Even & Clear Nourishing Daily Facial Moisturizer With Broad Spectrum SPF 30 Sunscreen, Net Wt. 1.7 FL. OZ. (50 mL)", "product_quantity": "Unknown", "reason_for_recall": "cGMP deviations: product stored outside of labeled temperature requirements.", "recall_initiation_date": "20220517", "center_classification_date": "20220531", "report_date": "20220608", "code_info": "SKUs 2096628."}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0214-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 50 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07082021:16 BUD: 10/23/2021; 08172021:26 BUD: 02/08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "73718", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1440-2016", "product_description": "Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL  33186; By Noven Pharmaceuticals, Inc., Miami, FL  33186, NDC 68968-5555-3.", "product_quantity": "12285 boxes", "reason_for_recall": "Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.", "recall_initiation_date": "20151221", "center_classification_date": "20160714", "termination_date": "20190319", "report_date": "20160720", "code_info": "Lot #s: 77379, 77380, Exp 05/16; 76944, Exp 03/16", "more_code_info": ""}, {"status": "Terminated", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75164", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS", "recall_number": "D-1533-2016", "product_description": "MOXI/DEX/KETOROLAC 0.5%/0.1%/0.4%, #15, Vital Care Compounder, Hattiesburg, MS 39402", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160726", "center_classification_date": "20160927", "termination_date": "20161118", "report_date": "20161005", "code_info": "Lot#:  399080, Use by 8-14-16; 399740, Use by 8-25-16; 398952, Use by 8-13-16; 398865, Use by 8-11-16; 399057, Use by 8-13-16; 398864, Use by 8-11-16"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0162-2015", "product_description": "Tri-mix T102, 17.65 mg/0.59 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08192014@18, Exp 11/17/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80980", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to hospitals in USA", "recall_number": "D-0003-2019", "product_description": "Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx only, QuVa Pharma, 519 Route 173, Bloombury, NJ 08804, UPC 70092103417.", "product_quantity": "528 bags", "reason_for_recall": "Subpotent Drug: Product may not have the active ingredient present in the bag.", "recall_initiation_date": "20180827", "center_classification_date": "20181001", "termination_date": "20190402", "report_date": "20180926", "code_info": "Lot #:30000271, Exp 10/1/18"}, {"country": "United States", "city": "Amityville", "address_1": "369 Bayview Ave", "reason_for_recall": "Subpotent; Cetylpyridinum Chloride", "address_2": "", "product_quantity": "10,440 bottles", "code_info": "Lot 611614 (exp. 09/2013)", "center_classification_date": "20130516", "distribution_pattern": "Puerto Rico", "state": "NY", "product_description": "BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 45 mg Zinc Chloride 30 mg), 1 Fl. Oz. (30 mL), Manufactured for GIL PHARMACEUTICAL CORP, PONCE, PUERTO RICO 00717-1565 -- NDC 58552-103-01", "report_date": "20130522", "classification": "Class III", "openfda": {}, "recalling_firm": "Hi-Tech Pharmacal Co., Inc.", "recall_number": "D-418-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64857", "termination_date": "20150430", "more_code_info": "", "recall_initiation_date": "20130408", "postal_code": "11701-2801", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1155-2019", "product_description": "HCG 40 Day Injection Extra Strength, vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "2 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0527-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Menstrual Cramps & Irregularities 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955500421, NDC 57955-5004-02", "product_quantity": "550 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 041416J Exp. 04/19; 070816F Exp. 07/19; 091015K Exp. 09/2018; 030218C Exp. 03/20"}, {"status": "Terminated", "city": "Boothwyn", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65180", "recalling_firm": "Pentec Health", "address_1": "4 Creek Pkwy Ste A", "address_2": "N/A", "postal_code": "19061-3132", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dialysis Centers  Direct to patient", "recall_number": "D-595-2013", "product_description": "Baxter LL bag 2% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysate solution with added amino acids), in a) 2500mL bag and b) 6000mL bag, Pentec Health Inc., 4 Creek Parkway Suite A, Boothwyn, PA  19061-3132", "product_quantity": "3 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.", "recall_initiation_date": "20130515", "center_classification_date": "20130606", "termination_date": "20141216", "report_date": "20130612", "code_info": "Compounding Date: a) 04/26/13, b) 04/30/13      Discard after: a) and b) 5/21/13"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73044", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0586-2016", "product_description": "Guaifenesin Grape liquid 100 mg/5 mL, packaged in 4oz. bottles, co-packaged with a dosing cup in a carton and sold under the following: a) H.E.B. Mucus Relief, Children's Guaifenesin, Expectorant, Age 4+, Grape Flavor, Gluten Free, Alcohol Free, 4 FL OZ (118 mL) Bottle, Made for: H.E.B. San Antonio, TX 78204, NDC 37808-288-26; b) CVS, Children's Mucus Relief Chest Congestion, Guaifenesin, Expectorant, Alcohol free, Gluten free, 4 FL OZ (118 mL) Bottle, For Ages 4 to 12 Years, Grape Flavor Liquid, Dosage Cup Included, Distributed by CVS Pharmacy Inc, One CVS Drive, Woonsocket, RI, 02895, NDC 59779-288-26.", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.", "recall_initiation_date": "20160108", "center_classification_date": "20160122", "termination_date": "20160518", "report_date": "20160203", "code_info": "Lot #s: 5MK0340, 5LK0592, Exp 08/17"}, {"status": "Terminated", "city": "Murray", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71989", "recalling_firm": "Novacare, LLC", "address_1": "312 W 6100 S", "address_2": "N/A", "postal_code": "84107-6990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0971-2016", "product_description": "Black Widow 25 Ephedra Super Potent Fat Burner Dietary Supplement packaged in 100 capsule containers. Distributed by Cloma Pharma Laboratories, Samford, CT 06902.", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.", "recall_initiation_date": "20150824", "center_classification_date": "20160606", "termination_date": "20170830", "report_date": "20160615", "code_info": "UPC 859613252258"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-0988-2016", "product_description": "1-HCG 1000 IU/ML, packaged in 5mL and 10mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01072016:  23@28, Exp. 04/06/2016; Lot #: 01082016:  27@1, Exp. 04/07/2016; Lot #:02012016:20@39, Exp. 05/01/2016; Lot #: 02022016:07@7, Exp.05/02/2016; Lot #: 02152016:29@50, Exp. 05/15/2016; Lot #: 02292016: 40@24, Exp.05/29/2016; Lot #: 02292016: 12@42 , Exp.05/29/2016; Lot #: 03042016:96@9, Exp.06/02/2016; Lot #: 03082016:59@34, Exp.06/08/2016  03142016:65@58, Exp.06/12/2016; Lot #: 03212016: 66@2, Exp.06/19/2016; Lot #: 03022016:50@38, Exp.06/23/2016; Lot #: 03302016: 93@11, Exp.      06/28/2016; Lot #: 04062016:79@22, Exp.07/07/2016; Lot #: 04122016    38@58, Exp.07/12/2016; Lot #: 04152016: 87@1, Exp. 07/14/2016; Lot #:  04152016:12@12, Exp. 07/14/2016; Lot #: 04222016: 55@27, Exp.07/21/2016"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:    0382303", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TROPICAMIDE OPHTHALMIC P.F. 1% SOLUTION\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1632-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0233-2025", "product_description": "Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-267-30.", "product_quantity": "175,920 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233792, Exp.: 8/2025; 19233795, Exp.: 8/2025; 19234258, Exp.: 9/2025; 19240912, Exp.: 2/2026; 19241476, 19241477, Exp.: 3/2026; 19242599, Exp.: 6/2026; 19243163, 19243162, Exp.:7/2026;19243884, 19243887, Exp.:9/2026."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA101995"], "brand_name": ["COLLAGENASE SANTYL"], "generic_name": ["COLLAGENASE SANTYL"], "manufacturer_name": ["SMITH & NEPHEW, INC"], "product_ndc": ["50484-010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["COLLAGENASE CLOSTRIDIUM HISTOLYTICUM"], "rxcui": ["309509"], "spl_id": ["155959d1-0367-4fb6-8877-29099d08801c"], "spl_set_id": ["6b6fbfc6-98fa-46aa-88ef-ab00fbb08ffd"], "package_ndc": ["50484-010-30", "50484-010-90"], "is_original_packager": [true], "upc": ["0350484010300"], "unii": ["9X7O8V25IT"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0567-2021", "product_description": "Collagenase Santyl Ointment 250 units/g 30 grams Rx Only Marketed by Smith & Nephew, Inc., Fort Worth, TX 76107, NDC 50484-010-30", "product_quantity": "1391 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "191960"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0242-2020", "product_description": "S-NANDROLONE DEC 200MG/ML MDV INJ in SESAME OIL, Rx Only, 10ml glass vial. Red Mountain Compounding Rx.", "product_quantity": "1x10ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S07022019DT@02, Exp 10/2/19"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "3000 mL in Vials", "code_info": "Lot #: 151220-5, BUD: 05/26/16;  Lot #: 160127-25, BUD: 07/25/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "M.I.C./B-COMPLEX (PF)  B1-50MG;B2-5-PO4-5MG;B3-50MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-5MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 2ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1221-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Fort Myers", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89356", "recalling_firm": "Medique Products", "address_1": "17080 Alico Commerce Ct Ste 1", "address_2": "N/A", "postal_code": "33967-8509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0389-2022", "product_description": "Physicians CARE Extra Strength PAIN RELIEVER [Acetaminophen, Aspirin (NSAID), and Caffeine], 250 mg, 250 mg, 65 mg, packaged as 100-count Tablets (50 Packets, 2 tablets each) per carton, Manufactured for: Acme United Corporation 55 Walls Dr, Fairfield, CT 06824, UPC 0 73577 90316 6", "product_quantity": "3,260,400 tablets", "reason_for_recall": "CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.", "recall_initiation_date": "20211206", "center_classification_date": "20220120", "termination_date": "20230621", "report_date": "20220126", "code_info": "Lots: (Packet, Carton) 6151, 4360 Exp. 10/2021; 6240, 4446 Exp. 12/2021; 6331, 4484 Exp. 02/2022; 6413, 4551 Exp. 04/2022; 6699, 4679 Exp. 10/2022; 6751, 4714 Exp. 12/2022; 6855, 4750 Exp. 01/2023; 6868, 4761 Exp. 02/2023; 6899, 4776 Exp. 02/2023; 6899, 4776 Exp. 02/2023; 7061, 4821 Exp. 05/2023."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-028-2014", "product_description": "Adenosine 35 mg/ml, 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "39 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79253", "recalling_firm": "Fagron, Inc", "address_1": "2400 Pilot Knob Rd", "address_2": "N/A", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, USA", "recall_number": "D-0547-2018", "product_description": "SyrSpend SF Suspending Base, a) 500 mL (NDC 51552-1079-5) and b) 4 L (NDC 51552-1079-9), Rx Only, Manufactured by Fagron Inc. St. Paul, MN 55120", "product_quantity": "a) 1007 bottles (500 mL) and b) 738 bottles (4 L)", "reason_for_recall": "Microbial contamination of Non-Sterile Product;  product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).", "recall_initiation_date": "20180214", "center_classification_date": "20180227", "termination_date": "20190910", "report_date": "20180307", "code_info": "a) 17I28-U80-039976, exp. 10/02/2020; b) 17I28-U80-039977, exp. 10/02/2020"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0252-2022", "product_description": "Tinactin (Tolnaftate 1%) JOCK ITCH POWDER SPRAY NET WT133g (4.6 oz) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland 20066104 UPC 3 11017 41007 3, NDC 11523-0072-5", "product_quantity": "592,416 cans", "reason_for_recall": "Chemical Contamination: presence of benzene", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot #   TN008M0, EXP 4/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Chester Springs", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86069", "recalling_firm": "Vilvet Pharmaceuticals Inc.", "address_1": "1208 Kimberton Rd Ste 101", "address_2": "", "postal_code": "19425-1437", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1487-2020", "product_description": "VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg methylene blue and 0.12 mg hyoscyamine sulfate), Rx Only, 100 Capsules per Bottle, Manufactured for: Vilvet Pharmaceuticals Inc., Chester Springs, PA 18425, NDC 71186-002-35.", "product_quantity": "11,640 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20200724", "center_classification_date": "20200806", "termination_date": "20220121", "report_date": "20200812", "code_info": "LOT M824H18-1 EXP 08/20  LOT M824J18-1 EXP 09/20  LOT M824L18-1 EXP 11/20  LOT M824A19-1 EXP 01/21  LOT M824C19-1 EXP 03/21  LOT M824G19-1 EXP 07/21", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0604-2022", "product_description": "Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, Packaged by Perrigo Company for: Big Lots Stores, Inc., P.O. Box 28523, Columbus, OH 43228-0523. NDC: 50594-719-10", "product_quantity": "3,168 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0827, Exp 12/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0029-2022", "product_description": "Magnesium Chloride, 200 mg/mL MDV INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0298-2017", "product_description": "Testosterone Cypionate in Sesame, 150 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "400 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05122016B (11/18/2016), 08012016C (01/28/2017), 09262016D (03/25/2017)."}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "6", "code_info": "B0021 Exp 8/31/13, B0013 Exp 8/1/13, C5122 Exp 9/22/13, C51101 Exp 8/1/13, C5508 Exp 9/8/13, and C5119 Exp 9/19/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-765-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0141-2022", "product_description": "QUAD-MIX PAPAV 30/PHENTOL 3/PGE-1 100/ATROPINE 0.2  INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07162021:24 BUD: 11/13/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0057-2017", "product_description": "ketamine HCl Injection, 50 mg per mL (100 mg per 2 mL), 2 mL Total Volume in a syringe, Rx only, PharMEDium, For IV Use, Product code 2R3500.", "product_quantity": "54 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 15117045M, 15120050M, 15131014M, Exp between 07/15/15-10/12/15"}, {"country": "United States", "city": "Morristown", "address_1": "36 Columbia Rd", "reason_for_recall": "Labeling: Incorrect/Undeclared Excipients: Firm is recalling A+D Diaper Rash Cream due to a labeling claim issue.", "address_2": "", "product_quantity": "a) 468,576 (1.5g); b) 203868 (3 oz) and c) 802,620 (4 oz)", "code_info": "a) Lot #: CV0068D, Exp. 12/31/2018; CV008N6, Exp. 2/28/2019; CV008N7, Exp. 3/31/2019; CV00BJA, Exp. 6/30/2019; CV00D0V and CV00DM4, Exp.8/31/2019.    b) Lot #: CV0068G, Exp. 12/31/2018; CV008N9, Exp. 3/31/2019; CV008N8, Exp. 4/30/2019; CV00D0U, Exp. 8/31/2019 and CV00G4U, Exp.10/31/2019.    c) Lot #: CV0068M, Exp. 12/31/2018; CV0068K, Exp.1/31/2019; CV008N5, Exp.  2/28/2019; CV008NC and CV008NE, Exp. 3/31/2019; CV008ND, CV008NB and CV008NA, Exp.4/30/2019; CV008NH, CV008NG and CV008NJ, Exp. 05/31/2019; CV00BJC, Exp.6/30/2019; CV00BJB, CV00BJE, CV00BJD, CV00BXB, CV00BXA and CV00BX9, Exp.7/31/2019; CV00D7H, CV00D7G, CV00D7E and CV00D7J, Exp. 8/31/2019; CV00E5T, CV00E5S and CV00E5R, Exp. 9/30/19; CV00G69 and CV00G6B, Exp.10/31/2019.", "center_classification_date": "20170321", "distribution_pattern": "US Nationwid, Puerto Rico, and Iceland", "state": "NJ", "product_description": "A+D Diaper Rash Cream with Dimethicone 1% and Zinc Oxide 10%, Packaged in a) 1.5 oz (42.5g) ( UPC 041100811288), b) 3 oz 85g (UPC 041100811301), c) 4 oz (113g) (UPC 041100811325), Distributed by: Bayer Healthcare LLC, Whippany, NJ 07981", "report_date": "20170329", "classification": "Class III", "openfda": {}, "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "recall_number": "D-0604-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76585", "termination_date": "20180103", "more_code_info": "", "recall_initiation_date": "20170221", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96853", "recalling_firm": "KABANA SKIN CARE", "address_1": "685 S Arthur Ave Unit 9b", "address_2": "N/A", "postal_code": "80027-3141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, FL, MI", "recall_number": "D-0512-2025", "product_description": "B Natural Organics, Organic Sunscreen, Broad Spectrum, SPF 30, 25% non-nano Zinc Oxide, a) Nude Tint Mineral Formula for Face and Body, 4 oz. (120 ML) per bottle. NDC: 73369-1002-2; b) Tint Free Mineral Formula for Face and Body, 4 oz. (120 ML) per bottle. NDC:  73369-1001-2; c) Tan Tint Mineral Formula for Face and Body, 4 oz. (120 ML) per bottle. NDC: 73369-1003-2.", "product_quantity": "204 tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250312", "center_classification_date": "20250710", "report_date": "20250716", "code_info": "Lots: a) 410-001, Exp 10/31/2027 b) 404-003, Exp 04/30/2027 c) 404-001, Exp 04/30/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040327"], "brand_name": ["ORPHENADRINE CITRATE"], "generic_name": ["ORPHENADRINE CITRATE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0185-0022"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ORPHENADRINE CITRATE"], "rxcui": ["994521"], "spl_id": ["de0e8cdb-788a-4ebe-969d-14d44a14ddc2"], "spl_set_id": ["239018ff-cec6-46de-ae9d-26c9ec034a32"], "package_ndc": ["0185-0022-10", "0185-0022-01"], "is_original_packager": [true], "unii": ["X0A40N8I4S"]}, "product_type": "Drugs", "event_id": "68860", "recalling_firm": "Sandoz Inc", "address_1": "506 Carnegie Ctr", "address_2": "", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1445-2014", "product_description": "Orphenadrine Citrate Extended Release Tablets, 100 mg  a)100-count bottle,  (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.", "product_quantity": "781,000 extended release tablets", "reason_for_recall": "Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.", "recall_initiation_date": "20140711", "center_classification_date": "20140723", "termination_date": "20170710", "report_date": "20140730", "code_info": "Lot # DM1316; Exp.  05/16  Lot # DM1318; Exp.  05/16", "more_code_info": ""}, {"status": "Terminated", "city": "Seattle", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85706", "recalling_firm": "BIOTA Biosciences LLC", "address_1": "1601 5th Ave Ste 1100", "address_2": "N/A", "postal_code": "98101-3603", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States and New Zealand", "recall_number": "D-1328-2020", "product_description": "Sterile Cannabidiol (CBD) 50mg/mL, 10mL vial", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin", "recall_initiation_date": "20200511", "center_classification_date": "20200619", "termination_date": "20201203", "report_date": "20200701", "code_info": "Lot #: 101019P, 1010019P,10102019P,  Exp. Date 10/10/2021"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "326 vials (10 mL each)", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Methylprednisolone Acetate injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-271-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Menlo Park", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA209310"], "brand_name": ["SINUVA"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Intersect ENT, Inc."], "product_ndc": ["10599-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRASINAL"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["1995983", "1995988"], "spl_id": ["508796b2-418c-402f-a33f-5766a8d4c18b"], "spl_set_id": ["e33c1b23-cdc6-4f64-94ba-24b0b42c09bf"], "package_ndc": ["10599-003-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "91348", "recalling_firm": "Intersect ENT, Inc.", "address_1": "1555 Adams Dr", "address_2": "N/A", "postal_code": "94025-1439", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0167-2023", "product_description": "SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025, NDC 10599-003-01.", "product_quantity": "9898 pouches", "reason_for_recall": "Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.", "recall_initiation_date": "20230104", "center_classification_date": "20230119", "termination_date": "20240821", "report_date": "20230125", "code_info": "Lot #s: 10111003, Exp 12/31/2022; 10203002, Exp 01/31/2023; 10302002, 10325001, Exp 02/28/2023; 10519001, 10526002, Exp 04/30/2023; 10602002, Exp 05/31/2023; 10819004, Exp 09/30/2023; 21092101, 21111901, Exp 10/31/2023; 21110402, Exp 12/31/2023."}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091226"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-3950", "0378-3951", "0378-3952", "0378-3953"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["c94bf799-ec3d-4644-b1a2-3c7b3f612e19"], "spl_set_id": ["d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d"], "package_ndc": ["0378-3950-77", "0378-3950-05", "0378-3950-09", "0378-3950-07", "0378-3951-77", "0378-3951-05", "0378-3951-09", "0378-3951-07", "0378-3952-77", "0378-3952-05", "0378-3952-09", "0378-3952-07", "0378-3953-77", "0378-3953-05", "0378-3953-09", "0378-3953-07"], "is_original_packager": [true], "upc": ["0303783953779", "0303783952772", "0303783950778", "0303783951775"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "76750", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0621-2017", "product_description": "Atorvastatin Calcium Tablets, 80 mg*, packaged in a) 90-count bottles (NDC 0378-3953-09) and b) 500-count bottles (NDC 0378-3953-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV  26505 U.S.A.", "product_quantity": "452,269 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.", "recall_initiation_date": "20170320", "center_classification_date": "20170328", "termination_date": "20180126", "report_date": "20170405", "code_info": "Lot #: a) 3073782, 3073783, Exp 02/18; 3074915, 3074916, 3074917, Exp 03/18; 3074918, 3075572, Exp 04/18; 3075573, 3075574, Exp 05/18; 2007226, 3075894, Exp 06/18; 2007344, 2007345, 2007346, Exp 08/18; 2007451, 2007452, 2007453, 2007454, Exp 09/18; b) 3070840, Exp 10/17; 3073781, 3074911, Exp 02/18; 3074912, 3074913, 3074914, Exp 03/18; 3075570, 3075571, Exp 04/18; 3075892, Exp 05/18; 3075893, Exp 06/18; 2007341, 2007342, 2007343, 2007347, Exp 08/18; 2007456, Exp 10/18", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: amLODIPine BESYLATE, Tablet, 5 mg may have potentially been mislabeled as the following drug:  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: W002839, EXP: 6/7/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "amLODIPine BESYLATE, Tablet, 5 mg has the following codes:   Pedigree: W002840, EXP: 6/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "amLODIPine BESYLATE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093716798.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-843-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0413-2023", "product_description": "Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 10 mL Multiple-dose vial in 10x10 carton, Rx Only, Manufactured for: Accord Healthcare, Inc. USA. Manufactured by: Intas Pharmaceuticals Limited, India, Vial NDC 16729-493-03, UPC 3 16729 49303 1; Carton NDC 16729-493-45, UPC 3 16729 49345 1.", "product_quantity": "48,089 cartons", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: R2101372, R2101397, R2101404, Exp. Date 4/30/2023; R2200264, R2200270, Exp. Date 8/31/2023; R2200382, Exp. Date 9/30/2023; R2200849, Exp. Date 12/31/2023; R2201017, R2201138, Exp. Date 1/31/2024; R2201249, Exp. Date 2/29/2024", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["MLK KIT F2"], "generic_name": ["MARCAINE, LIDOCAINE, KENALOG, POVIDONE IODINE"], "manufacturer_name": ["Advanced Rx of Tennessee, LLC"], "product_ndc": ["80425-0508"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "INTRA-ARTICULAR", "INTRAMUSCULAR", "TOPICAL"], "rxcui": ["797730", "1724880", "1737761", "1792144"], "spl_id": ["325d8b0c-da34-376b-e063-6394a90acdde"], "spl_set_id": ["325d93c6-d97b-a45c-e063-6294a90a974f"], "package_ndc": ["80425-0508-1", "0409-1162-18", "55150-165-05", "70121-1049-5", "67777-419-02"], "original_packager_product_ndc": ["76420-742"]}, "product_type": "Drugs", "event_id": "84241", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0573-2020", "product_description": "Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in 10 x 5 mL Single Dose Vials per carton, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ  08520, NDC 55150-165-05.", "product_quantity": "111,850 vials", "reason_for_recall": "Presence of Foreign Substance: Foreign material found inside the vial.", "recall_initiation_date": "20191111", "center_classification_date": "20191205", "termination_date": "20201117", "report_date": "20191204", "code_info": "Batch #: CLC190049, Exp 02/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["DRY EYE RELIEF"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0089"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED"], "rxcui": ["579907"], "spl_id": ["b2fd3f1c-69bb-4c0c-9a11-1c135377045c"], "spl_set_id": ["bd262028-32e9-052d-e053-2a95a90a5303"], "package_ndc": ["70000-0089-1"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0299-2024", "product_description": "Leader brand Dry Eye Relief (Carboxymethylcellulose Sodium 1%), packaged in 0.5 FL OZ (15 mL) bottles, Cardinal Health Dublin, Ohio 43017, NDC 70000-0089-1", "product_quantity": "23,208 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; hydrALAZINE HCl Tablet, 50 mg may be potentially mislabeled as    CapsuleTOPRIL, Tablet, 12.5 mg, NDC 00143117101, Pedigree: AD52778_16, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "hydrALAZINE HCl, Tablet, 50 mg has the following code    Pedigree: AD52778_28, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "hydrALAZINE HCl Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111032801", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-591-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0605-2020", "product_description": "Fentanyl Citrate and Clonidine HCL and Morphine Sulfate and Baclofen in all strengths, all doses and all packaging,  AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled and dispensed on 08/26-29/2019 and 09/27/2019 through 10/03/2019 remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0913-2019", "product_description": "NET Remedies #11 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "1700 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-050516J Exp. 05/19; AUS-030917D Exp. 03/20; AUS-011916L Exp. 01/19; AUS-011117H Exp. 01/20"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83711", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to 1 physician in Gainesville  Florida.", "recall_number": "D-1877-2019", "product_description": "Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09", "product_quantity": "79 (90 ct.) bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20190829", "center_classification_date": "20190924", "termination_date": "20230424", "report_date": "20191002", "code_info": "Lot #: G0219K, Exp 3/2021; C1419E, Exp 3/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96996", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0498-2025", "product_description": "LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative-Free, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0000-0.", "product_quantity": "29,700 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.", "recall_initiation_date": "20250602", "center_classification_date": "20250630", "report_date": "20250709", "code_info": "Lot #s: 2502004, Exp. 2/18/27; 2503003, Exp. 3/19/27", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "43 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03162015@8, 6/14/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 20 mg/ml + Clonidine 1,000 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1670-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0207-2018", "product_description": "7-Keto DHEA 25mg Capsule, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "90 capsules", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 06082017@36 BUD: 12/5/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Sandpoint", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68222", "recalling_firm": "Thorne Research Inc", "address_1": "25820 Hwy 2 West", "address_2": "N/A", "postal_code": "83864", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Visit", "distribution_pattern": "Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.", "recall_number": "D-1383-2014", "product_description": "Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 74002 5", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.", "recall_initiation_date": "20140612", "center_classification_date": "20140613", "termination_date": "20141015", "report_date": "20140625", "code_info": "All lot codes", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0453-2020", "product_description": "OCuSOFT retaine NaCl Sodium Chloride Hypertonicity Ophthalmic Ointment, 0.5 fl oz. (15mL), Distributed by OCuSOFT, Inc. Rosenberg, TX 77471 USA", "product_quantity": "13626  units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 18008    1/20        19105    4/22"}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64716", "recalling_firm": "Pallimed Solutions", "address_1": "400 W Cummings Park", "address_2": "", "postal_code": "01801-6519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-874-2013", "product_description": "Quadmix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130325", "center_classification_date": "20130809", "termination_date": "20130821", "report_date": "20130821", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0691-2022", "product_description": "Halobetasol Propionate Ointment, 0.05%, Net Wt. 50 grams tube, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-998-67.", "product_quantity": "21,323 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15720, Exp. 6/30/2022; 16449, 16450, Exp. 2/28/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-662-2015", "product_description": "Ethopropazine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202494"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-6637", "0409-4916"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["727995", "792582"], "spl_id": ["f79ec8cb-b6a3-4ffb-bccf-d39f59d65621"], "spl_set_id": ["ea20a5eb-641e-48cd-bcfa-74c04c45dfda"], "package_ndc": ["0409-4916-24", "0409-4916-14", "0409-6637-24", "0409-6637-14"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "93681", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0234-2024", "product_description": "8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).", "product_quantity": "21200 Cartons", "reason_for_recall": "Presence of Particulate Matter; identified as glass", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot HA7295, EXP 03/01/2025"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA004782"], "brand_name": ["PREMARIN"], "generic_name": ["ESTROGENS, CONJUGATED"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "product_ndc": ["0046-1100", "0046-1101", "0046-1102", "0046-1104", "0046-1103"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESTROGENS, CONJUGATED"], "rxcui": ["150840", "197660", "197661", "197662", "202301", "208513", "208949", "310197", "403849", "404550"], "spl_id": ["5d5aaac9-95da-4d88-817b-bca1c40739c9"], "spl_set_id": ["258e1602-a3cf-4ccc-ca80-73dbbfb812ff"], "package_ndc": ["0046-1101-81", "0046-1102-81", "0046-1102-91", "0046-1102-52", "0046-1104-81", "0046-1104-91", "0046-1100-81", "0046-1100-91", "0046-1100-52", "0046-1103-81"], "is_original_packager": [true], "upc": ["0300461103815", "0300461101811"], "nui": ["N0000175825", "N0000000100", "M0007792"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "pharm_class_cs": ["Estrogens, Conjugated (USP) [CS]"], "unii": ["IU5QR144QX"]}, "product_type": "Drugs", "event_id": "75225", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1528-2016", "product_description": "PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91", "product_quantity": "1,316 bottles (1,316,000 tablets)", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.", "recall_initiation_date": "20160915", "center_classification_date": "20160927", "termination_date": "20170809", "report_date": "20161005", "code_info": "Lot  # M35953S; Exp. 11/17 (labeled)."}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0522-2018", "product_description": "Sumatriptan USP for prescription compounding, packaged in 10g (NDC 58597-8089-3); b) 25g (NDC 58597-8089-4); c)100g (NDC 58597-8089-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "10000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) SUT1213030SP-11192014, Exp. 11/30/2018; b) SUT1213030SP-11192014, exp. 11/30/2018; c) SUT1213030SP-7222015, Exp.11/30/2018."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "86 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03162015@54, 6/14/2015; 04222015@14, 7/21/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 15 mg/ml Solution, Sterile-Preservative Free,  The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1587-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "70552", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia", "recall_number": "D-0963-2015", "product_description": "Fluorescein Sodium Ophthalmic Strips USP, 1.0 mg per strip, labeled as 1) FUL-GLO, individually wrapped strips, barcode (01)00317478404019; packaged in 100-count strips per carton, (NDC 17478-404-01), UPC 3 17478 40401 9, Manufactured for: Akorn, Inc., Lake Forest, IL 60045.; and 2)Fluorescein Pro Glo Strips, individually wrapped strips, barcode (01)00360843000026, packaged in 300-count strips per carton, (NDC 60843-300-50), UPC 3 60843 30050 8, Manufactured for Eye Care and Cure by Nomax, Inc., St. Louis, MO 63123.", "product_quantity": "62,691 cartons", "reason_for_recall": "Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of fluorescein present in the strips.", "recall_initiation_date": "20150324", "center_classification_date": "20150421", "termination_date": "20170221", "report_date": "20150429", "code_info": "1) FUL-GLO Lot: 8980, Exp 10/15; 9081, Exp 01/16; 9088, Exp 02/16; 9128 and 9158, Exp 03/16; 2) Pro Glo Lot: 9082, Exp 01/17", "more_code_info": ""}]